mediMACH
Media planning and audience analytics software for market-media studies.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- mediMACH GmbH & Co. KG
- Entity type
- COMPANY
- Founded
- 2004
- Headquarters
- Germany
- Market role
- AdTech Vendor
- Official website
- medimach.com
What mediMACH does
mediMACH runs a specialised B2B software business built around proprietary media planning and analysis tools. It creates value by integrating industry-standard market-media studies into a unified interface that supports reach analysis, audience overlap evaluation, benchmarking, forecasting, and reporting. Customers embed the platform into recurring planning workflows, which makes the software operationally useful for campaign development, cross-media comparison, and internal reporting. The company complements the platform with training and support services that improve onboarding and retention.
Category differentiation
mediMACH is not a consumer media property, ad network, or full-service agency. It is a specialised B2B software provider for media planning, audience analysis, and market-media study evaluation.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
mediMACH GmbH & Co. KG is a German private software company that develops and licenses mediMACH, a web-based market and media planning platform used for audience analysis, reach evaluation, media comparison, and campaign planning. Its core products, including mediMACH Online and mediMACH Professional, enable agencies, media planners, marketing teams, analysts, and media owners to work with standard market-media studies such as AWA and ma inside a single workflow. The company generates revenue through recurring licensed access to its software and associated study-based data access, with a higher-tier professional offering for more advanced users and organisational needs. Its commercial position sits at the intersection of advertising technology and B2B SaaS, focused on analytics, planning efficiency, and standardised use of established media research datasets in the German market.
Business model & monetisation
mediMACH monetises through subscription-style licensed access to its software platform, primarily via named-user access to mediMACH Online and related professional tiers. Revenue is also tied to access to embedded market-media study datasets, creating a hybrid of software subscription and data-access licensing. Premium functionality and enterprise-grade workflows support tiered pricing, while training and onboarding services provide ancillary service revenue.
- Software licences for mediMACH Online
- Named-user software subscription
- Professional-tier product access
- Tiered software subscription
- Access to market-media study datasets
- Data access licensing
- Training and onboarding resources
- Service fee
Products & capabilities
No products with linked sources are available in this view.
Products & market categories
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
b4t brands 2026-2 zum Auswerten mit mediMACH verfügbar
Recorded impact score: 3/5
Am 04.09.2026 wurde b4t brands 2026-2 zum Auswerten mit mediMACH verfügbar gemacht. Zudem sind Vorabtarife PZ 2027 in mediMACH verfügbar.
Explore company relationships
Questions about mediMACH
What is mediMACH?
mediMACH is a German B2B software company that provides web-based media planning and audience analytics tools built around standard market-media studies.
Who uses mediMACH?
Media agencies, media planners, marketing teams, media owners, and professional analysts use mediMACH for reach analysis, comparison, forecasting, and reporting.
How does mediMACH make money?
mediMACH makes money through licensed software access, tiered professional product subscriptions, study-linked data access, and related training or support services.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
14 publicly documented primary sources and citations linked across the market graph.
Continue your research on mediMACH
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.